Concord Biotech Ltd. logo

Concord Biotech Ltd. share price

NSE: CONCORDBIO · Healthcare

₹581.00 -2.19%

Closing price data, updated 17 Nov 2026. 52-week range: -28.1% from high, +17.7% above low.

Price₹581.00
Market cap₹6,078 Cr
P/E21.6
P/B2.93
ROE13.6%
ROCE16.7%
Debt / equity0.00
Dividend yield0.00%
EPS₹26.84
Book value₹198.42
Operating margin29.1%
Dipscan score57 / 100
Open full analysis, charts & financials →

Share: WhatsAppX / TwitterTelegram

Concord Biotech Ltd. shareholding pattern

As of Sep 2026: Promoters 44.09%, FIIs 7.28%, DIIs 10.95%, Government 0.00%, Public 8.81%, Others 28.87%.

HolderSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025
Promoters44.09%44.08%44.08%44.08%44.08%44.08%
FIIs7.28%7.52%7.80%7.58%8.03%9.11%
DIIs10.95%9.36%9.22%9.58%9.55%8.87%
Government0.00%0.00%0.00%0.00%0.00%0.00%
Public8.81%8.23%8.09%8.11%7.77%7.43%
Others28.87%30.81%30.81%30.64%30.56%30.51%
No. of Shareholders88,36583,32582,24981,81582,65082,045

As filed by the company with the exchanges.

Returns

1 day1 week1 month3 months6 months1 year
-2.19%-8.16%-15.93%-20.11%+1.93%-20.06%

Growth

Sales growth, 3 years+8.0%
Sales growth, 5 years–
Profit growth, 3 years+2.8%
Profit growth, 5 years–
Latest quarter sales vs last year+25.1%
Latest quarter profit vs last year+11.1%

Strengths and weaknesses

Strengths

Weaknesses

Peers in Healthcare

CompanyPriceMarket capP/EROE1 year
Sun Pharmaceutical Industries ₹1,867.50₹4,48,076 Cr40.914.7%+8.8%
Divi's Laboratories Ltd.₹11,080.00₹2,94,139 Cr87.516.2%+69.4%
Torrent Pharmaceuticals Ltd.₹4,691.20₹1,78,438 Cr84.027.1%+22.6%
Apollo Hospitals Enterprise Lt₹8,771.00₹1,26,114 Cr56.221.9%+16.9%
Laurus Labs Ltd.₹2,220.00₹1,19,949 Cr89.518.2%+125.2%
Zydus Lifesciences Ltd.₹1,192.00₹1,18,902 Cr28.419.7%+27.0%
Dr. Reddy's Laboratories Ltd.₹1,377.90₹1,14,778 Cr41.012.1%+13.7%
Cipla Ltd.₹1,394.50₹1,12,658 Cr38.911.8%-8.0%

Frequently asked questions

What is the share price of Concord Biotech Ltd.?

Concord Biotech Ltd. (CONCORDBIO) last closed at ₹581.00 (-2.19% on the day).

What is the market cap of Concord Biotech Ltd.?

About ₹6,078 Cr.

What is the P/E ratio of Concord Biotech Ltd.?

The price-to-earnings ratio is 21.6, and return on equity is 13.6%.

Figures are calculated from company results and exchange prices and are for information only.